IGF-1 LR3 vs PEG-MGF: Anabolic Pathway Research

IGF-1 LR3 ("Long R3 IGF-1") is an 83-residue analog of insulin-like growth factor 1 with two key modifications: an N-terminal 13-residue extension and an Arg³ substitution. These changes reduce binding to IGF-binding proteins (IGFBPs), increasing free-fraction availability in serum.

PEG-MGF is mechano growth factor — a splice variant of IGF-1 (also called IGF-1Ec) — chemically modified with polyethylene glycol to extend its plasma half-life from minutes to hours. MGF's C-terminal E-domain confers receptor binding distinct from IGF-1 itself.

In C2C12 myoblast proliferation assays, IGF-1 LR3 shows greater potency on a molar basis due to its IGFBP evasion. PEG-MGF is typically studied for its reported effects on satellite cell activation — a distinct biological readout from generic IGF-1R agonism.

Both peptides require careful reconstitution due to their relatively large size and tendency to aggregate. Dilute slowly with bacteriostatic water and avoid vigorous agitation.

For in vitro research use only.